In addition, metformin reduced the expression of several proteins related to immune responses, including VTCN1, a B7 family member involved in immune regulation, as well as IRF4, a regulator of lymphocyte growth and differentiation, leading to decreased tumor cell proliferation and metastasis [73–75]. This evidence concerns the gene VTCN1 and neoplasm.